Clinical Study Results
Where can I learn more about this study?
You can find more information about this study on the websites listed below. If a full report
of the study results is available, it also can be found there.
• www.clinicaltrials.gov. Once you are on the website, type “NCT02908750” into the
search box and click “Search”.
• www.clinicaltrialsregister.eu. Once you are on the website, click
“Home & Search”, then type “2016-002525-11” in the search box and
click “Search”.
The full title of your study is: An Open-label, Non-randomised, Phase I Study to
Assess the Effect of Single and Multiple Oral Doses of Osimertinib (TAGRISSO™) on
the Pharmacokinetics of a P-glycoprotein Probe Drug (Fexofenadine) in Patients with
Advanced EGFRm NSCLC that have Progressed on a Prior EGFR-TKI Regimen
The protocol number of your study is: D5160C00036
AstraZeneca AB sponsored this study and has its headquarters at
1800 Concord Pike, Wilmington, DE 19850.
The phone number for the AstraZeneca Information Center is 1-877-240-9479.
Thank you
Clinical study participants belong to a large community of people who take part in clinical
research around the world. They help researchers answer important health questions and
find medical treatments for participants.
The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization focused
on educating and informing the public about clinical research participation. CISCRP is not involved in recruiting
participants for clinical studies, nor is it involved in conducting clinical studies.
CISCRP • One Liberty Square, Suite 510 • Boston, MA 02109
1-877-MED-HERO • www.ciscrp.org
4
Version: V2.0 06/2018